◼ Archived
Business
🔮 fades ✗
In autopsy of failed heart disease study, AstraZeneca raises broader questions about silencer drugs
A failed clinical trial by AstraZeneca and Ionis for eplontersen raises critical questions about the efficacy of silencer drugs in treating heart disease.